Invesco Nasdaq Biotechnology ETF Price & Performance (IBBQ)

U.S. equity futures and ETFs experienced declines in premarket trading today, reflecting heightened fears of a potential recession. Key indices like the S&P 500 and Dow Jones Industrial Average saw declines, while technology and energy ETFs showed mixed performance. Investors are closely watching economic data releases for further market direction.1

2Seventy Bio’s shares surged 77% after Bristol Myers Squibb announced a $5 per share acquisition deal. The move highlights the growing consolidation trend in the biotech sector, as larger firms target smaller companies to strengthen their portfolios. Analysts predict further mergers could reshape the industry landscape.2

Celsius Holdings announced a $1.8 billion acquisition of Alani Nutrition, signaling growth in the energy drink sector. The cash-and-stock deal positions Celsius to expand its market share amid increasing consumer demand for functional beverages. The acquisition reflects broader trends of consolidation in consumer-focused industries.3